Addressing rising concerns regarding the risks affecting Africa’s health security
“I envy the man who has yet been to Africa, for he has much to see” – Richard Mullin
About Us
MMH & Partners Africa (MMH) was established to address rising concerns regarding the risks affecting Africa’s health security and medicine supply, due to its dependency on foreign imports from the Global North.
The MMH team has since been capacitated to assist in the facilitation and establishment of a new public health order for Africa, one in which the equitable access to healthcare products is never compromised by global supply or local demand.
Our panel of highly-skilled experts have over 60 years of combined experience in Africa’s healthcare sector and pharmaceutical manufacturing industries, offering private companies and donor funders with access to a number of opportunities geared to unlock growth in Africa’s public and private health sectors.
Our Services
Team of Experts
MMH & Partners Africa have curated a team of industry experts to assist private and public market players in collaborating successfully towards improving Africa’s capacity to produce and manufacture medicines and healthcare products on the continent.
Raising of Capital
Our team remains well-positioned to assist key stakeholders with raising capital for healthcare infrastructure in Africa. This includes services related to business strategy, due diligence, feasibility and market shaping, IC document preparation and policy writing.
Expert Assistance
At MMH, we are able to assist with event planning, stakeholder engagement, networking and all facets of regulatory trading to limit any barriers to entry to the market.
Project Management
We have spent a number of years successfully managing large-scale investments into pharmaceutical manufacturing sites, and can assist with all associated aspects of project management, including the physical construction of new production facilities for diagnostics, pharmaceuticals and biologics across Africa.
MMH & Partners in the Media
MMH & Partners Africa regularly communicates on its industry insights, offering key stakeholders, government officials and citizens across the African continent with access to the latest developments and challenges affecting Africa’s medicine supply and health security. The latest news and groundbreaking industry insights from our highly-qualified team of experts can be accessed at your
Resources
For access to our strategic recommendations for the development of Southern Africa’s pharmaceutical manufacturing framework, as prepared at the request of H.E. President Cyril Ramaphosa for the Presidency of the Republic of South Africa, please see below. This section includes our Medical Journal Articles and policy position papers as drafted in collaboration with industry experts.
26 November 2023
Industry Overview & Strategic Recommendations
This position paper offers the Presidency of the Republic of South Africa and the National Department of Health (DOH) with invaluable industry insights by MMH & Partners, Africa (Pty) Ltd, towards achieving a new public health order for Africa based on six strategic objectives.
07 October 2023
Addressing Regulatory Challenges
Citing conditions affecting the development of Africa’s new public health order, industry experts in The Hague agreed that a global regulatory standard would remain a critical undertaking to decrease Africa’s reliance on foreign healthcare products and imports.
25 August 2023
Expansion of Pharmaceutical Manufacturing in SA
Reports have confirmed that the United States Congress has failed to reauthorise a five-year budget for the world’s largest aid programme for global health, by its 30 September deadline in 2023.
17 July 2023
Improving Medicine Security in Africa
In Africa, 99% of all vaccines administered to people are imported. The consequences of this are notably concerning – and became painfully evident after COVID-19.
December 2023
Pandemic Preparedness & Response
WHO’s scientific research and findings must incentivise public and private stakeholders to work together to spearhead the development of Africa’s pharmaceutical and biological manufacturing framework if we want to improve our ability to prevent, detect and limit the transmission of HIV.
25 October 2023
Human Capital Development in Africa
Africa, a continent of immense potential, has long grappled with complex healthcare challenges. The COVID -19 pandemic has accentuated the urgency of fortifying the continent’s healthcare infrastructure. At the heart of this transformation lies the imperative of human capital development in bio & pharma-manufacturing.
Contact Us
Your message has been sent
MMH & Partners Africa 